| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 403 | 1,831 | 26,277 | 10,615 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 403 | 1,831 | 26,277 | 10,615 | | | Operating Expenses | | Research Development | 17,000 | 15,250 | 21,767 | 22,303 | | Selling General and Administrative | 8,116 | 7,834 | 7,707 | 7,743 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (24,713) | (21,253) | (3,197) | (19,431) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 226 | 351 | 503 | 706 | | Earnings Before Interest And Taxes | (24,487) | (20,902) | (2,694) | (18,725) | | Interest Expense | 24 | 12 | 4 | 17 | | Income Before Tax | (24,511) | (20,914) | (2,698) | (18,742) | | Income Tax Expense | (137) |
-
|
-
| (16) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (24,374) | (20,914) | (2,698) | (18,726) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (24,374) | (20,914) | (2,698) | (18,726) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($24,374) | ($20,914) | ($2,698) | ($18,726) |
|
0.29% Nasdaq 0.00%
Income Statement
